Here's a conference breakdown of the latest AP Top 25

1,002 Views | 10 Replies | Last: 1 yr ago by Johnny Bear
gobears20
How long do you want to ignore this user?
Staff
Johnny Bear
How long do you want to ignore this user?
Not hard to see which conference is top to bottom the best.
Task Force 2015
How long do you want to ignore this user?
Particularly because the Big 12 has only 10 teams.
historian
How long do you want to ignore this user?
It will be very interesting to see how many of the 10 will get into the tournament.
Fre3dombear
How long do you want to ignore this user?
No Duke. No UNC
LIB,MR BEARS
How long do you want to ignore this user?
Fre3dombear said:

No Duke. No UNC
UNC will be back. Duke, perhaps not.
whitetrash
How long do you want to ignore this user?
B1G has only 2 ranked, yet Lunardi is projecting 10 will make the tournament. That's gonna make a lot of first round losses.
Johnny Bear
How long do you want to ignore this user?
Also posted this in another thread, but just to provide a little more perspective on the level of respect for the B12 - the aggys have presently won 6 straight and stand at 4-0 in the SEC with a 12-5 overall record and according to Lunardi aren't even in the Tournament field as things stand now. They're currently one of the "first 4 out" as is WVU - with their 0-5 B12 record.
EvilTroyAndAbed
How long do you want to ignore this user?
Add Houston into that mix, and it's laughable. Actually, it's already laughable.
BluesBear
How long do you want to ignore this user?
BYU is nothing to sneeze at either....this conference for BB is going to be sick.....already got my tickets for the B!2 Tournament...
Johnny Bear
How long do you want to ignore this user?
EvilTroyAndAbed said:

Add Houston into that mix, and it's laughable. Actually, it's already laughable.


Yes, it's already laughable, but after UH gets added in the B12 is really going to be the SEC of men's basketball.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.